卡撒天嬌(02223.HK)中期純利260萬港元 同比上升約62.6%
格隆匯8月26日丨卡撒天嬌(02223.HK)公吿,截至2022年6月30日止六個月,公司銷售收入總額為港幣1.44億元,對比2021年同期輕微上升0.7%;公司擁有人應占溢利港幣260萬元,對比2021年同期上升約62.6%。
儘管集團收入在相約水平,溢利增加乃主要由於截至2022年6月30日止六個月錄得其他收入╱收益增加,其中包括收到部份香港政府就2022保就業計劃的新冠疫情相關補貼及出售物業、廠房及設備的收益所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.